Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 854-863

  Konter, Jason M ^a   Parker, Jennifer L ^a   Baez, Elizabeth ^a   Li, Stephanie Z ^a   Ranscht, Barbara ^b   Denzel, Martin ^b   Little, Frederic F ^a   Nakamura, Kazuto ^a   Ouchi, Noriyuki ^a   Fine, Alan ^a   Walsh, Kenneth ^a   Summer, Ross S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CADHERIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 6; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; T CADHERIN; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; WILD TYPE;

ACUTE LUNG INJURY; ADIPONECTIN; ANIMALS; CADHERINS; CELL LINE, TUMOR; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; INTERLEUKIN-6; INTUBATION, INTRATRACHEAL; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PULMONARY ARTERY;

EID: 84862922916     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100426     Document Type: Article

References (43)

1. Rubenfeld, G. D., E. Caldwell, E. Peabody, J. Weaver, D. P. Martin, M. Neff, E. J. Stern, and L. D. Hudson. 2005. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353: 1685-1693. (Pubitemid 41464707)
2. Orfanos, S. E., I. Mavrommati, I. Korovesi, and C. Roussos. 2004. Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med. 30: 1702-1714. (Pubitemid 39297172)
3. Tsushima, K., L. S. King, N. R. Aggarwal, A. De Gorordo, F. R. D'Alessio, and K. Kubo. 2009. Acute lung injury review. Intern. Med. 48: 621-630.
4. Stapleton, R. D., A. E. Dixon, P. E. Parsons, L. B. Ware, and B. T. Suratt; NHLBI Acute Respiratory Distress Syndrome Network. 2010. The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest 138: 568-577.
5. Gong, M. N., E. K. Bajwa, B. T. Thompson, and D. C. Christiani. 2010. Body mass index is associated with the development of acute respiratory distress syndrome. Thorax 65: 44-50.
6. Towfigh, S., M. V. Peralta, M. J. Martin, A. Salim, R. Kelso, H. Sohn, T. V. Berne, and R. J. Mason. 2009. Acute respiratory distress syndrome in nontrauma surgical patients: a 6-year study. J. Trauma 67: 1239-1243.
7. Anzueto, A., F. Frutos-Vivar, A. Esteban, N. Bensalami, D. Marks, K. Raymondos, C. Apezteguía, Y. Arabi, J. Hurtado, M. González, et al Ventila Group. 2011. Influence of body mass index on outcome of the mechanically ventilated patients. Thorax 66: 66-73.
8. Gajic, O., O. Dabbagh, P. K. Park, A. Adesanya, S. Y. Chang, P. Hou, H. Anderson III, J. J. Hoth, M. E. Mikkelsen, N. T. Gentile, et al. 2011. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am. J. Respir. Crit. Care Med. 183: 462-470.
9. Libby, P., Y. Okamoto, V. Z. Rocha, and E. Folco. 2010. Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 74: 213-220.
10. Pischon, T., C. J. Girman, G. S. Hotamisligil, N. Rifai, F. B. Hu, and E. B. Rimm. 2004. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291: 1730-1737. (Pubitemid 38489895)
11. Takemura, Y., K. Walsh, and N. Ouchi. 2007. Adiponectin and cardiovascular inflammatory responses. Curr. Atheroscler. Rep. 9: 238-243. (Pubitemid 47629071)
12. Weyer, C., T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R. E. Pratley, and P. A. Tataranni. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86: 1930-1935. (Pubitemid 32472900)
13. Yamauchi, T., J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-946. (Pubitemid 32756432)
14. Arita, Y., S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257: 79-83. (Pubitemid 29299050)
15. Ouchi, N., S. Kihara, T. Funahashi, Y. Matsuzawa, and K. Walsh. 2003. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 14: 561-566. (Pubitemid 41623184)
16. Stefan, N., B. Vozarova, T. Funahashi, Y. Matsuzawa, C. Weyer, R. S. Lindsay, J. F. Youngren, P. J. Havel, R. E. Pratley, C. Bogardus, and P. A. Tataranni. 2002. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51: 1884-1888. (Pubitemid 34564302)
17. Tilg, H., and A. R. Moschen. 2008. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin. Sci. 114: 275-288. (Pubitemid 351294003)
18. Holland, W. L., R. A. Miller, Z. V. Wang, K. Sun, B. M. Barth, H. H. Bui, K. E. Davis, B. T. Bikman, N. Halberg, J. M. Rutkowski, et al. 2011. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17: 55-63.
19. Durante-Mangoni, E., R. Zampino, A. Marrone, M. F. Tripodi, L. Rinaldi, L. Restivo, M. Cioffi, G. Ruggiero, and L. E. Adinolfi. 2006. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/ tumour necrosis factor-α in chronic hepatitis C patients. Aliment. Pharmacol. Ther. 24: 1349-1357. (Pubitemid 44571565)
20. Engeli, S., M. Feldpausch, K. Gorzelniak, F. Hartwig, U. Heintze, J. Janke, M. Möhlig, A. F. H. Pfeiffer, F. C. Luft, and A. M. Sharma. 2003. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52: 942-947. (Pubitemid 36384264)
21. Krakoff, J., T. Funahashi, C. D. A. Stehouwer, C. G. Schalkwijk, S. Tanaka, Y. Matsuzawa, S. Kobes, P. A. Tataranni, R. L. Hanson, W. C. Knowler, and R. S. Lindsay. 2003. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26: 1745-1751. (Pubitemid 36929114)
22. Ouchi, N., S. Kihara, T. Funahashi, T. Nakamura, M. Nishida, M. Kumada, Y. Okamoto, K. Ohashi, H. Nagaretani, K. Kishida, et al. 2003. Reciprocal association of C-reactive protein with adiponectin in bloodstream and adipose tissue. Circulation 107: 671-674. (Pubitemid 36222590)
23. Summer, R., F. F. Little, N. Ouchi, Y. Takemura, T. Aprahamian, D. Dwyer, K. Fitzsimmons, B. Suki, H. Parameswaran, A. Fine, and K. Walsh. 2008. Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L1035-L1042.
24. Ohashi, K., N. Ouchi, K. Sato, A. Higuchi, T. O. Ishikawa, H. R. Herschman, S. Kihara, and K. Walsh. 2009. Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism. Mol. Cell. Biol. 29: 3487-3499.
25. Shibata, R., K. Sato, D. R. Pimentel, Y. Takemura, S. Kihara, K. Ohashi, T. Funahashi, N. Ouchi, and K. Walsh. 2005. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11: 1096-1103. (Pubitemid 41486832)
26. Chen, B., W.-Q. Liao, N. Xu, H. Xu, J.-Y. Wen, C.-A. Yu, X.-Y. Liu, C.-L. Li, S.- M. Zhao, and W. Campbell. 2009. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res. 1273: 129-137.
27. Matsumoto, H., S. Tamura, Y. Kamada, S. Kiso, J. Fukushima, A. Wada, N. Maeda, S. Kihara, T. Funahashi, Y. Matsuzawa, et al. 2006. Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice. World J. Gastroenterol. 12: 3352-3358. (Pubitemid 43933779)
28. Summer, R., C. A. Fiack, Y. Ikeda, K. Sato, D. Dwyer, N. Ouchi, A. Fine, H. W. Farber, and K. Walsh. 2009. Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. Am. J. Physiol. Lung Cell Mol. Physiol. 297: L432-L438.
29. Takemura, Y., N. Ouchi, R. Shibata, T. Aprahamian, M. T. Kirber, R. S. Summer, S. Kihara, and K. Walsh. 2007. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J. Clin. Invest. 117: 375-386. (Pubitemid 46203966)
30. Zhu, M., C. Hug, D. I. Kasahara, R. A. Johnston, A. S. Williams, N. G. Verbout, H. Si, J. Jastrab, A. Srivastava, E. S. Williams, et al. 2010. Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice. Am. J. Respir. Cell Mol. Biol. 43: 487-497.
31. Denzel, M. S., M.-C. Scimia, P. M. Zumstein, K. Walsh, P. Ruiz-Lozano, and B. Ranscht. 2010. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J. Clin. Invest. 120: 4342-4352.
32. Wyder, L., A. Vitaliti, H. Schneider, L. W. Hebbard, D. R. Moritz, M. Wittmer, M. Ajmo, and R. Klemenz. 2000. Increased expression of H/T-cadherin in tumor-penetrating blood vessels. Cancer Res. 60: 4682-4688.
33. Sridulyakul, P., D. Chakraphan, P. Bhattarakosol, and S. Patumraj. 2003. Endothelial nitric oxide synthase expression in systemic and pulmonary circulation of streptozotocin induced diabetic rats: comparison using image analysis. Clin. Hemorheol. Microcirc. 29: 423-428. (Pubitemid 38130416)
34. Aird, W. C. 2007. Phenotypic heterogeneity of the endothelium. II. Representative vascular beds. Circ. Res. 100: 174-190. (Pubitemid 46208718)
35. Medoff, B. D., Y. Okamoto, P. Leyton, M. Weng, B. P. Sandall, M. J. Raher, S. Kihara, K. D. Bloch, P. Libby, and A. D. Luster. 2009. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am. J. Respir. Cell Mol. Biol. 41: 397-406.
36. Nakagawa, Y., K. Kishida, S. Kihara, T. Funahashi, and I. Shimomura. 2009. Adiponectin ameliorates hypoxia-induced pulmonary arterial remodeling. Biochem. Biophys. Res. Commun. 382: 183-188.
37. Nakanishi, K., Y. Takeda, S. Tetsumoto, T. Iwasaki, K. Tsujino, H. Kuhara, Y. Jin, I. Nagatomo, H. Kida, S. Goya, et al. 2011. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. Am. J. Respir. Crit. Care Med. 183: 1164-1175.
38. Uji, Y., H. Yamamoto, H. Tsuchihashi, K. Maeda, T. Funahashi, I. Shimomura, T. Shimizu, Y. Endo, and T. Tani. 2009. Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery 145: 550-557.
39. Tsuchihashi, H., H. Yamamoto, K. Maeda, S. Ugi, T. Mori, T. Shimizu, Y. Endo, K. Hanasawa, and T. Tani. 2006. Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J. Surg. Res. 134: 348-353. (Pubitemid 44092804)
40. Walkey, A. J., T. W. Rice, J. Konter, N. Ouchi, R. Shibata, K. Walsh, B. P. deBoisblanc, and R. Summer. 2010. Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit. Care Med. 38: 2329-2334.10.1097/CCM.1090b1013e3181fa0561.
41. Fantuzzi, G. 2005. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115: 911-919, quiz 920.
42. Bellmeyer, A., J. M. Martino, N. S. Chandel, G. R. Scott Budinger, D. A. Dean, and G. M. Mutlu. 2007. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am. J. Respir. Crit. CareMed. 175: 587-594. (Pubitemid 46438943)
43. Munzberg, H. 2010. Leptin-signaling pathways and leptin resistance. Forum Nutr. 63: 123-132.